KYOPRAME Trademark
Trademark Overview
On Friday, February 23, 2024, a trademark application was filed for KYOPRAME with the United States Patent and Trademark Office. The USPTO has given the KYOPRAME trademark a serial number of 98418327. The federal status of this trademark filing is WITHDRAWN BEFORE PUBLICATION as of Thursday, February 27, 2025. This trademark is owned by Immunocore Limited. The KYOPRAME trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
General Information
| Serial Number | 98418327 |
| Word Mark | KYOPRAME |
| Filing Date | Friday, February 23, 2024 |
| Status | 692 - WITHDRAWN BEFORE PUBLICATION |
| Status Date | Thursday, February 27, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 18, 2025 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Immunocore Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Oxfordshire OX144RY
GB |
Trademark Events
| Event Date | Event Description |
| Friday, February 23, 2024 | NEW APPLICATION ENTERED |
| Monday, July 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 6, 2024 | ASSIGNED TO EXAMINER |
| Saturday, September 7, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, September 7, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, September 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, December 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 24, 2025 | ASSIGNED TO EXAMINER |
| Monday, February 24, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, February 27, 2025 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
